Alto Neuroscience (ANRO) Profit After Tax (2023 - 2026)

Alto Neuroscience has reported Profit After Tax for 4 years, with the latest figure at -$26.2 million in Q1 2026.

• Quarterly Profit After Tax fell 22914.78% year-over-year to -$26.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.1 million (down 530.17% YoY) and the FY2025 annual result came in at $123000.0, up 659.09% from the prior year.
• Profit After Tax fell to -$26.2 million in Q1 2026 per ANRO's latest filing, from $8000.0 in the prior quarter.
• Over five years, Profit After Tax peaked at $46.2 million in Q4 2024 and troughed at -$26.2 million in Q1 2026.
• A 4-year average of -$5.7 million and a median of -$8.7 million in 2023 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 660014.29% in 2024, down 167730.0% in 2024.
• Over 4 years, Profit After Tax stood at $7000.0 in 2023, then jumped by 660014.29% to $46.2 million in 2024, then tumbled by 99.98% to $8000.0 in 2025, then tumbled by 328062.5% to -$26.2 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$26.2 million, $8000.0, and -$14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.